Vertex Pharmaceuticals Management Performance Evaluation

VRTX -- USA Stock  

Fiscal Quarter End: December 31, 2019  

Break down of Vertex Pharmaceuticals manpower and management performance that can provide insight into the company performance. Note, an employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Vertex Pharmaceuticals future performance. Vertex Pharmaceuticals employes about 2500 people. The company is managed by 26 executives with total tenure of roughly 91 years, averanging almost 3.0 years of service per executive having 1.0 employee per reported executive. Also please take a look at World Market Map.
  Joshua Boger  Chairman
Executive Director and Chairman of Science and Technology Committee
  Jeffrey Leiden  Chairman
Chairman of the Board and Presidentident, CEO
  Reshma Kewalramani  President
Executive Vice President - Global Medicines Development and Medical Affairs and Chief Medical Officer

Vertex Pharmaceuticals Management Effectiveness

The company has return on total asset (ROA) of 8.3 % which means that it generated profit of $8.3 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 51.75 % meaning that it created $51.75 on every $100 dollars invested by stockholders.

Vertex Pharmaceuticals Workforce Comparison

Vertex Pharmaceuticals Incorpor is rated below average in number of employees category among related companies. The total workforce of Biotechnology industry is at this time estimated at about 55,299. Vertex Pharmaceuticals holds roughly 2,500 in number of employees claiming about 5% of stocks in Biotechnology industry.

Vertex Pharmaceuticals Profit Margins

The company has Profit Margin (PM) of 59.24 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 25.01 % which suggests for every 100 dollars of sales it generated a net operating income of 0.25.

Vertex Pharmaceuticals Insider Trading

Vertex Pharmaceuticals Benchmark Summation

The output start index for this execution was eleven with a total number of output elements of fifty. The Lowest value over a specified period line plots minimum value of Vertex Pharmaceuticals price series. View also all equity analysis or get more info about lowest value over a specified period math operators indicator.

Vertex Pharmaceuticals Stakeholders

Joshua Boger Executive Director and Chairman of Science and Technology Committee
Jeffrey Leiden Chairman of the Board and Presidentident, CEO
Reshma Kewalramani Executive Vice President - Global Medicines Development and Medical Affairs and Chief Medical Officer
Michael Parini Executive Vice President and Chief Legal Officer
John Gray Senior Vice President Genetic Therapies
Ian Smith CFO, Executive Vice President
Paul Silva Senior Vice President Corporate Controller
Jeffrey Chodakewitz Chief Medical Officer and Senior Vice President - Global Medicines Development
Amit Sachdev Senior Vice President - Global Government Strategy, Market Access and Value
Charles Wagner CFO, Executive Vice President
Michael Partridge Vice President - Investor Relations
Kimberly White Senior Vice President and Chief Communications Officer
Thomas Graney CFO, Senior Vice President
Charles Milstein Executive Vice President Chief Legal and Administrative Officer
Stuart Arbuckle Chief Commercial Officer and Executive VP
William Young Independent Director
Alan Garber Independent Director
Margaret McGlynn Independent Director
Sangeeta Bhatia Director
Terrence Kearney Independent Director
David Altshuler Independent Director
Elaine Ullian Co-Lead Independent Director
David Greenway Director
Bruce Sachs Co-Lead Independent Director
Lloyd Carney Independent Director
Yuchun Lee Independent Director

Vertex Pharmaceuticals Manpower Efficiency

Return on Vertex Pharmaceuticals Manpower

Revenue Per Employee901.1 K
Revenue Per Executive139.2 M
Net Income Per Employee400.9 K
Net Income Per Executive82.3 M
Working Capital Per Employee360.3 K
Working Capital Per Executive34.6 M

Per Employee

Vertex Pharmaceuticals Per Employee Growth Over Time

Net Income Per Employee
Revenue Per Employee
Also please take a look at World Market Map. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.
Search macroaxis.com